Dr. Uzzo on Unmet Needs in Kidney Cancer

Robert G. Uzzo, MD
Published: Wednesday, Oct 04, 2017



Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses pressing unmet needs for patients with kidney cancer.

Biomarkers remain to be a pressing unmet need for patients with kidney cancer because without them it is difficult to stratify risks, explains Uzzo.

It is also important to be aware that there are trade-offs with kidney cancer management. Active surveillance may also begin to play a role in this treatment landscape, states Uzzo.
 


Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses pressing unmet needs for patients with kidney cancer.

Biomarkers remain to be a pressing unmet need for patients with kidney cancer because without them it is difficult to stratify risks, explains Uzzo.

It is also important to be aware that there are trade-offs with kidney cancer management. Active surveillance may also begin to play a role in this treatment landscape, states Uzzo.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Oncology Briefings™: Overcoming Chronic Iron Overload in Pediatric AML and MDSJun 30, 20181.0
Publication Bottom Border
Border Publication
x